We are live on ! Find out more
OPRX icon

OptimizeRx

13 hedge funds and large institutions have $21.3M invested in OptimizeRx in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

17.71% more ownership

Funds ownership: 0%17.71% (+18%)

Holders
13
Holders Change
+13
Holders Change %
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

OPRX Hedge Fund Activity: Q2 2018 in Review

13 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q2 2018, worth a combined $21.3M.

Buyers outnumbered sellers: 13 funds opened new OPRX positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $7.65M.

  • 13 institutional investors held OptimizeRx (OPRX) as of Q2 2018, up from 0 in Q1 2018.
  • Funds reported $21.3M of OptimizeRx stock for Q2 2018.
  • 13 funds opened new OptimizeRx positions in Q2 2018 and 0 closed out, a net change of +13 holders.
  • The largest OptimizeRx buyer in Q2 2018 was Wolverine Asset Management, an estimated $7.65M added.

Based on aggregated 13F filings for Q2 2018.